A Danish Pragmatic Randomized Trial of Nutritional Supplements in Heart Failure
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 4044 participants.
Also called NCT06694727
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 4,044 participants
- Sponsor
- Registry
-
NCT06694727
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Denmark
- Registry status
- Recruiting
Technical summary
Registry record NCT06694727. Randomized; quadruple masking; primary purpose treatment. Start 2025-09-30 (actual); primary completion 2028-12-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Danish Pragmatic Randomized Trial of Nutritional Supplements in Heart Failure
- Acronym
- DANUTRIO-HF
- Condition
- Heart Failure
- Intervention (Dietary supplement)
- Coenzyme Q10 100 Milligrams Oral Capsule
- Intervention (Dietary supplement)
- Selenium 100 Micrograms Oral Tablets
- Lead sponsor
- Tor Biering-Sørensen
- Collaborator
- Pharma Nord
Record details
- Record id
cardio:ct-nct06694727- Content hash
31d1a9eacd832376c7ecf5c06f726e75dd62edac029b7ffef8cab14082ab2e3e